Amicoat Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 8

Amicoat General Information

Description

Provider of biotechnology services intended to help in developing novel antimicrobial products. The company's services involve developing and commercializing antimicrobial technology that inhibits bacterial growth and the formation of bio-films, enabling industries to addresses the issue of bacterial and fungal contamination in medical devices and the global prevalence of hospital-acquired infections.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Elias Smiths vei 24
  • Sandvika
  • 1337 Oslo
  • Norway
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amicoat Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view Amicoat’s complete valuation and funding history, request access »

Amicoat Executive Team (4)

Name Title Board Seat Contact Info
Georg Gundersen Ph.D Chief Executive Officer
Kjetil Vangsnes Chief Financial Officer
John Svendsen Ph.D Chief Scientific Officer
To view Amicoat’s complete executive team members history, request access »

Amicoat Board Members (4)

Name Representing Role Since
Erik Rosen Self Board Member 000 0000
Gert Munthe Self Chairman 000 0000
Gunnar Saelid Self Board Member 000 0000
Knut Eidissen Picasso Kapital Board Member 000 0000
To view Amicoat’s complete board members history, request access »

Amicoat Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Care Holding Other Minority 000 0000 000000 0
Hopen Invest Other Minority 000 0000 000000 0
Jakob Hatteland Logistics Corporation Minority 000 0000 000000 0
Lysnes Invest Other Minority 000 0000 000000 0
NorInnova Invest Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »